Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma

被引:25
作者
Abdulkhalek, Samar [1 ,2 ]
Geen, Olivia D. [1 ,2 ]
Brodhagen, Lacey [1 ,2 ]
Haxho, Fiona [1 ,2 ]
Alghamdi, Farah [1 ,2 ]
Allison, Stephanie [3 ]
Simmons, Duncan J. [1 ,2 ]
O'Shea, Leah K. [1 ,2 ]
Neufeld, Ronald J. [3 ]
Szewczuk, Myron R. [1 ,2 ]
机构
[1] Queens Univ, Dept Biomed, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Mol Sci, Kingston, ON K7L 3N6, Canada
[3] Queens Univ, Chem Engn, Kingston, ON K7L 3N6, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Human ovarian cancer; Tumor neovascularization; Silencing transcriptional repressors Snail and Slug; Oseltamivir phosphate;
D O I
10.1186/s40169-014-0028-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Snail, a transcriptional factor and repressor of E-cadherin is well known for its role in cellular invasion. It can regulate epithelial to mesenchymal transition (EMT) during embryonic development and in epithelial cells. Snail also mediates tumor progression and metastases. Silencing of Snail and its associate member Slug in human A2780 ovarian epithelial carcinoma cell line was investigated to identify its role in tumor neovascularization. Methods: Live cell sialidase, WST-1 cell viability and immunohistochemistry assays were used to evaluate sialidase activity, cell survival and the expression levels of tumor E-cadherin, N-cadherin, VE-cadherin, and host endothelial CD31+(PECAM-1) cells in archived paraffin-embedded ovarian A2780, A2780 Snail shRNA GIPZ lentiviral knockdown (KD) and A2780 Slug shRNA GIPZ lentiviral KD tumors grown in RAGxC gamma double mutant mice. Results: Oseltamivir phosphate (OP), anti-Neu1 antibodies and MMP-9 specific inhibitor blocked Neu1 activity associated with epidermal growth factor (EGF) stimulated A2780 ovarian epithelial carcinoma cells. Silencing Snail in A2780 cells abrogated the Neu1 activity following EGF stimulation of the cells compared to A2780 and A2780 Slug KD cells. OP treatment of A2780 and cisplatin-resistant A2780cis cells reproducibly and dose-dependently abated the cell viability with a LD50 of 7 and 4 mu M, respectively, after 48 h of incubation. Heterotopic xenografts of A2780 and A2780 Slug KD tumors developed robust and bloody tumor vascularization in RAG2xC gamma double mutant mice. OP treatment at 50 mg/kg daily intraperitoneally did not significantly impede A2780 tumor growth rate but did cause a significant reduction of lung metastases compared with the untreated and OP 30mg/kg cohorts. Silencing Snail in A2780 tumor cells completely abrogated tumor vascularization, tumor growth and spread to the lungs in RAGxC gamma double mutant mice. A2780 and A2780 Slug KD tumors expressed high levels of human N-and VE-cadherins, and host CD31+ endothelial cells, while A2780 Snail KD tumors expressed E-cadherin and reduced host CD31+ cells. OP 50mg/kg cohort tumors had reduced numbers of host CD31+ cells compared to a higher expression levels of CD31+ cells in tumors from the untreated control and OP 30mg/kg cohorts. Conclusion: Snail transcriptional factor is an important intermediate player in human ovarian tumor neovascularization.
引用
收藏
页数:16
相关论文
共 64 条
[1]   A novel G-protein-coupled receptor-signaling platform and its targeted translation in human disease [J].
Abdulkhalek, Samar ;
Hrynyk, Michael ;
Szewczuk, Myron R. .
RESEARCH AND REPORTS IN BIOCHEMISTRY, 2013, 3 :17-30
[2]   Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and-9 activation, cellular signaling and pro-inflammatory responses [J].
Abdulkhalek, Samar ;
Szewczuk, Myron R. .
CELLULAR SIGNALLING, 2013, 25 (11) :2093-2105
[3]   G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signaling [J].
Abdulkhalek, Samar ;
Guo, Merry ;
Amith, Schammim Ray ;
Jayanth, Preethi ;
Szewczuk, Myron R. .
CELLULAR SIGNALLING, 2012, 24 (11) :2035-2042
[4]   Neu1 Sialidase and Matrix Metalloproteinase-9 Cross-talk Is Essential for Toll-like Receptor Activation and Cellular Signaling [J].
Abdulkhalek, Samar ;
Amith, Schammim Ray ;
Franchuk, Susan L. ;
Jayanth, Preethi ;
Guo, Merry ;
Finlay, Trisha ;
Gilmour, Alanna ;
Guzzo, Christina ;
Gee, Katrina ;
Beyaert, Rudi ;
Szewczuk, Myron R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (42) :36532-36549
[5]   A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes [J].
Alghamdi, Farah ;
Guo, Merry ;
Abdulkhalek, Samar ;
Crawford, Nicola ;
Amith, Schammim Ray ;
Szewczuk, Myron R. .
CELLULAR SIGNALLING, 2014, 26 (06) :1355-1368
[6]   Neu1 desialylation of sialyl α-2,3-linked β-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling [J].
Amith, Schammim Ray ;
Jayanth, Preethi ;
Franchuk, Susan ;
Finlay, Trisha ;
Seyrantepe, Volkan ;
Beyaert, Rudi ;
Pshezhetsky, Alexey V. ;
Szewczuk, Myron R. .
CELLULAR SIGNALLING, 2010, 22 (02) :314-324
[7]   Dependence of pathogen molecule-induced Toll-like receptor activation and cell function on Neu1 sialidase [J].
Amith, Schammim Ray ;
Jayanth, Preethi ;
Franchuk, Susan ;
Siddiqui, Sarah ;
Seyrantepe, Volkan ;
Gee, Katrina ;
Basta, Sameh ;
Beyaert, Rudi ;
Pshezhetsky, Alexey V. ;
Szewczuk, Myron R. .
GLYCOCONJUGATE JOURNAL, 2009, 26 (09) :1197-1212
[8]  
Amith SR, 2010, JOVE J VISUALIZED EX
[9]   Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents [J].
Bamias, Aristotle ;
Bamia, Christine ;
Zagouri, Flora ;
Kostouros, Efthimios ;
Kakoyianni, Konstantina ;
Rodolakis, Alexandros ;
Vlahos, George ;
Haidopoulos, Dimitrios ;
Thomakos, Nikolaos ;
Antsaklis, Aris ;
Dimopoulos, Meletios-Athanasios .
ONCOLOGY, 2013, 84 (03) :158-165
[10]   Correlation of Snail expression with histological grade and lymph node status in breast carcinomas [J].
Blanco, MJ ;
Moreno-Bueno, G ;
Sarrio, D ;
Locascio, A ;
Cano, A ;
Palacios, J ;
Nieto, MA .
ONCOGENE, 2002, 21 (20) :3241-3246